Co-Founder, Non-Executive Director
Werner Cautreels, Ph.D. is a co-founder and Non-Executive Director of ACCOY Pharmaceuticals, Inc. He retired as the President and CEO of Selection BioSciences (which he took public via a NASDAQ IPO in 2016) in December 2018. Prior to Selecta Biosciences, Dr. Cautreels was CEO of Solvay Pharmaceuticals, the pharmaceuticals division of the Solvay Group (Brussels, Belgium) until Solvay Pharmaceuticals was acquired by Abbott Laboratories in February 2010 for $6.6 billion. Before becoming the CEO of Solvay Pharmaceuticals, Dr. Cautreels was their Global Head of R&D. Prior to joining Solvay, he was employed by Sanofi, Sterling-Winthrop, and Nycomed-Amersham in a variety of R&D management positions in Europe and in the United States. Dr. Cautreels was a director of Selecta BioSciences from 2010 to 2018, Innogenetics NV (Gent, Belgium) and of Arqule Inc. (Woburn, MA, USA) from 1999-2006. He is currently a director of Galapagos NV (Mechelen, Belgium) and ACCOY Pharmaceuticals, Inc.. He was the President of the Belgian-Luxemburg Chamber of Commerce for Russia and Belarus until June 2010. He was born in Antwerp, Belgium, and graduated from the University of Antwerp, gaining a Doctorate in Chemistry, specializing in Mass Spectrometry. He received his management education from the Harvard Business School.
The ACCOY System, ACCOY, ACCOYRX and API are Trademarks and Servicemarks of Accoy Pharmaceuticals, Inc.
© by Accoy Pharmaceuticals, Inc., 2019. All rights reserved.